February 28, 2024 · Form 4 insider transaction
BENEVICH ERIC bought 21,857 shares of Neurocrine Biosciences, Inc. at $79.02 per share, a transaction worth $1.73M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.